Global Prostate Cancer Diagnostics Market Size, Share

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Prostate Cancer Diagnostics Market Size Analysis

Global Prostate Cancer Diagnostics Market Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Preliminary Tests
  1. By Value
  2. PSA Tests
    1. PSA Tests By Value
  3. Free PSA Test
    1. Free PSA Test By Value
  4. Total PSA Test
    1. Total PSA Test By Value
  5. Other Preliminary Tests
    1. Other Preliminary Tests By Value
3. Confirmatory Tests
  1. By Value
  2. Pca3 Test
    1. Pca3 Test By Value
  3. Trans-Rectal Ultrasound
    1. Trans-Rectal Ultrasound By Value
  4. Biopsy Test
    1. Biopsy Test By Value
By Type
1. Introduction
  1. Type By Value
2. Adenocarcinoma
  1. By Value
3. Interstitial Cell Carcinoma
  1. By Value
4. Other
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Outpatient Facilities
  1. By Value
4. Home Care
  1. By Value
5. Others
  1. By Value

North America Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Preliminary Tests
  1. By Value
  2. PSA Tests
    1. PSA Tests By Value
  3. Free PSA Test
    1. Free PSA Test By Value
  4. Total PSA Test
    1. Total PSA Test By Value
  5. Other Preliminary Tests
    1. Other Preliminary Tests By Value
3. Confirmatory Tests
  1. By Value
  2. Pca3 Test
    1. Pca3 Test By Value
  3. Trans-Rectal Ultrasound
    1. Trans-Rectal Ultrasound By Value
  4. Biopsy Test
    1. Biopsy Test By Value
By Type
1. Introduction
  1. Type By Value
2. Adenocarcinoma
  1. By Value
3. Interstitial Cell Carcinoma
  1. By Value
4. Other
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Outpatient Facilities
  1. By Value
4. Home Care
  1. By Value
5. Others
  1. By Value
U.S.
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Preliminary Tests
    1. By Value
    2. PSA Tests
      1. PSA Tests By Value
    3. Free PSA Test
      1. Free PSA Test By Value
    4. Total PSA Test
      1. Total PSA Test By Value
    5. Other Preliminary Tests
      1. Other Preliminary Tests By Value
  3. Confirmatory Tests
    1. By Value
    2. Pca3 Test
      1. Pca3 Test By Value
    3. Trans-Rectal Ultrasound
      1. Trans-Rectal Ultrasound By Value
    4. Biopsy Test
      1. Biopsy Test By Value
2. By Type
  1. Introduction
    1. Type By Value
  2. Adenocarcinoma
    1. By Value
  3. Interstitial Cell Carcinoma
    1. By Value
  4. Other
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Outpatient Facilities
    1. By Value
  4. Home Care
    1. By Value
  5. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Preliminary Tests
  1. By Value
  2. PSA Tests
    1. PSA Tests By Value
  3. Free PSA Test
    1. Free PSA Test By Value
  4. Total PSA Test
    1. Total PSA Test By Value
  5. Other Preliminary Tests
    1. Other Preliminary Tests By Value
3. Confirmatory Tests
  1. By Value
  2. Pca3 Test
    1. Pca3 Test By Value
  3. Trans-Rectal Ultrasound
    1. Trans-Rectal Ultrasound By Value
  4. Biopsy Test
    1. Biopsy Test By Value
By Type
1. Introduction
  1. Type By Value
2. Adenocarcinoma
  1. By Value
3. Interstitial Cell Carcinoma
  1. By Value
4. Other
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Outpatient Facilities
  1. By Value
4. Home Care
  1. By Value
5. Others
  1. By Value
U.K.
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Preliminary Tests
    1. By Value
    2. PSA Tests
      1. PSA Tests By Value
    3. Free PSA Test
      1. Free PSA Test By Value
    4. Total PSA Test
      1. Total PSA Test By Value
    5. Other Preliminary Tests
      1. Other Preliminary Tests By Value
  3. Confirmatory Tests
    1. By Value
    2. Pca3 Test
      1. Pca3 Test By Value
    3. Trans-Rectal Ultrasound
      1. Trans-Rectal Ultrasound By Value
    4. Biopsy Test
      1. Biopsy Test By Value
2. By Type
  1. Introduction
    1. Type By Value
  2. Adenocarcinoma
    1. By Value
  3. Interstitial Cell Carcinoma
    1. By Value
  4. Other
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Outpatient Facilities
    1. By Value
  4. Home Care
    1. By Value
  5. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Preliminary Tests
  1. By Value
  2. PSA Tests
    1. PSA Tests By Value
  3. Free PSA Test
    1. Free PSA Test By Value
  4. Total PSA Test
    1. Total PSA Test By Value
  5. Other Preliminary Tests
    1. Other Preliminary Tests By Value
3. Confirmatory Tests
  1. By Value
  2. Pca3 Test
    1. Pca3 Test By Value
  3. Trans-Rectal Ultrasound
    1. Trans-Rectal Ultrasound By Value
  4. Biopsy Test
    1. Biopsy Test By Value
By Type
1. Introduction
  1. Type By Value
2. Adenocarcinoma
  1. By Value
3. Interstitial Cell Carcinoma
  1. By Value
4. Other
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Outpatient Facilities
  1. By Value
4. Home Care
  1. By Value
5. Others
  1. By Value
China
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Preliminary Tests
    1. By Value
    2. PSA Tests
      1. PSA Tests By Value
    3. Free PSA Test
      1. Free PSA Test By Value
    4. Total PSA Test
      1. Total PSA Test By Value
    5. Other Preliminary Tests
      1. Other Preliminary Tests By Value
  3. Confirmatory Tests
    1. By Value
    2. Pca3 Test
      1. Pca3 Test By Value
    3. Trans-Rectal Ultrasound
      1. Trans-Rectal Ultrasound By Value
    4. Biopsy Test
      1. Biopsy Test By Value
2. By Type
  1. Introduction
    1. Type By Value
  2. Adenocarcinoma
    1. By Value
  3. Interstitial Cell Carcinoma
    1. By Value
  4. Other
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Outpatient Facilities
    1. By Value
  4. Home Care
    1. By Value
  5. Others
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Preliminary Tests
  1. By Value
  2. PSA Tests
    1. PSA Tests By Value
  3. Free PSA Test
    1. Free PSA Test By Value
  4. Total PSA Test
    1. Total PSA Test By Value
  5. Other Preliminary Tests
    1. Other Preliminary Tests By Value
3. Confirmatory Tests
  1. By Value
  2. Pca3 Test
    1. Pca3 Test By Value
  3. Trans-Rectal Ultrasound
    1. Trans-Rectal Ultrasound By Value
  4. Biopsy Test
    1. Biopsy Test By Value
By Type
1. Introduction
  1. Type By Value
2. Adenocarcinoma
  1. By Value
3. Interstitial Cell Carcinoma
  1. By Value
4. Other
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Outpatient Facilities
  1. By Value
4. Home Care
  1. By Value
5. Others
  1. By Value
UAE
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Preliminary Tests
    1. By Value
    2. PSA Tests
      1. PSA Tests By Value
    3. Free PSA Test
      1. Free PSA Test By Value
    4. Total PSA Test
      1. Total PSA Test By Value
    5. Other Preliminary Tests
      1. Other Preliminary Tests By Value
  3. Confirmatory Tests
    1. By Value
    2. Pca3 Test
      1. Pca3 Test By Value
    3. Trans-Rectal Ultrasound
      1. Trans-Rectal Ultrasound By Value
    4. Biopsy Test
      1. Biopsy Test By Value
2. By Type
  1. Introduction
    1. Type By Value
  2. Adenocarcinoma
    1. By Value
  3. Interstitial Cell Carcinoma
    1. By Value
  4. Other
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Outpatient Facilities
    1. By Value
  4. Home Care
    1. By Value
  5. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Preliminary Tests
  1. By Value
  2. PSA Tests
    1. PSA Tests By Value
  3. Free PSA Test
    1. Free PSA Test By Value
  4. Total PSA Test
    1. Total PSA Test By Value
  5. Other Preliminary Tests
    1. Other Preliminary Tests By Value
3. Confirmatory Tests
  1. By Value
  2. Pca3 Test
    1. Pca3 Test By Value
  3. Trans-Rectal Ultrasound
    1. Trans-Rectal Ultrasound By Value
  4. Biopsy Test
    1. Biopsy Test By Value
By Type
1. Introduction
  1. Type By Value
2. Adenocarcinoma
  1. By Value
3. Interstitial Cell Carcinoma
  1. By Value
4. Other
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Outpatient Facilities
  1. By Value
4. Home Care
  1. By Value
5. Others
  1. By Value
Brazil
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Preliminary Tests
    1. By Value
    2. PSA Tests
      1. PSA Tests By Value
    3. Free PSA Test
      1. Free PSA Test By Value
    4. Total PSA Test
      1. Total PSA Test By Value
    5. Other Preliminary Tests
      1. Other Preliminary Tests By Value
  3. Confirmatory Tests
    1. By Value
    2. Pca3 Test
      1. Pca3 Test By Value
    3. Trans-Rectal Ultrasound
      1. Trans-Rectal Ultrasound By Value
    4. Biopsy Test
      1. Biopsy Test By Value
2. By Type
  1. Introduction
    1. Type By Value
  2. Adenocarcinoma
    1. By Value
  3. Interstitial Cell Carcinoma
    1. By Value
  4. Other
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Outpatient Facilities
    1. By Value
  4. Home Care
    1. By Value
  5. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Prostate Cancer Diagnostics Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

MDx Health
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Myriad Genetics, Inc.
Abbott Laboratories
Hoffman-La Roche AG
Bayer AG
Siemens Healthcare GmbH
OPKO Health, Inc.
Genomic Health.
Pfizer Inc.
Proteomedix
Beckman Coulter, Inc.
Quest Diagnostics

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment